Loading clinical trials...
Loading clinical trials...
The investigators want to study the JAK-inhibitors and their impact on the immune system and evaluate the potential of a gene-therapeutic strategy
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
prof. dr. Rik Schrijvers
Collaborators
NCT06076642 · Primary Immunodeficiency Diseases (PID)
NCT05755035 · Primary Immunodeficiency Diseases (PID)
NCT05513586 · Primary Immunodeficiency Diseases (PID)
NCT03277313 · Primary Immunodeficiency Diseases (PID)
NCT01218438 · Primary Immunodeficiency Diseases (PID)
University Hospitals Leuven,
Leuven, Vlaams-Brabant
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions